Show me all projects in
Explore 396 projects in United States
MedStartr
The world's first Healthcare Crowdfunding platform. We help healthcare ideas, research, and companies get found and funded faster.
Avado: Patient Relationship Management
1st Accelerated Client: Raised $7,586 on MedStartr, 1.3 M elsewhere, and bought by WebMD in just 15 months!
Captricity
The best way to turn paper forms into digital data. <p></p> <p><strong>Captricity got 4,000 views and raised 1.6 M offline</strong></p>
EndoGoddess Diabetes App: Clinical Trial Fundraiser
EndoGoddess V.2.0: Rewarding Healthy Behavior for Diabetics. Project: Development and Clinical Trial.
Peer-to-Peer Global Support for Rare Disease
Undisputed online health information users, rare disease patients connect across the globe with social media-based support group FMD Chat.
Reconstruction Bras For Breast Cancer Survivors and Previvors
Reconstructed bras for Reconstructed Girls (breast cancer survivors and previvors)!
The Walking Gallery
We are the Wall that Walks.
Your Nurse is On
Update: Now Intelliblast - Next round closing soon! Get in while you can.
Saving 100 Lives With The Patient Pod
"Your portable patient advocate – because knowledge is power."
DeathPanels.com
Kickstart a spiritual movement to re-frame the debate over end-of-life health care in America. Support the DeathPanels.com project now!
Pedi Glove - disposable foot protection and therapy
Grossed out walking around your bacteria infested health club pool and shower? Slip on antifungal biodegradeable Pedi Gloves to be safe
My Crisis Records
What vital information can you share when this happens?
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.